Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/01/2014US8765790 Positive allosteric modulators of nicotinic acetylcholine receptor
07/01/2014US8765789 2-pyridinecarboxamide derivatives
07/01/2014US8765788 Tricyclic inhibitors of hydroxysteroid dehydrogenases
07/01/2014US8765787 Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
07/01/2014US8765785 Solifenacin salts
07/01/2014US8765784 Positive allosteric modulators of MGLUR2
07/01/2014US8765783 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation
07/01/2014US8765782 Indole derivatives as selective androgen receptor modulators (SARMS)
07/01/2014US8765781 Bis-carbazole DNA intercalating agents for antitumor therapy
07/01/2014US8765780 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
07/01/2014US8765779 Tricyclic derivatives and their pharmaceutical use and compositions
07/01/2014US8765778 Rifamycin derivatives
07/01/2014US8765777 Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection
07/01/2014US8765776 Antihypertensive pharmaceutical composition
07/01/2014US8765775 Anti-angiogenic compounds
07/01/2014US8765774 3-arylquinazolin-4-one compounds for combating invertebrate pests
07/01/2014US8765773 Substituted hydroxamic acids and uses thereof
07/01/2014US8765772 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
07/01/2014US8765771 Condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
07/01/2014US8765770 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators
07/01/2014US8765769 Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases
07/01/2014US8765768 Heterocyclic compounds and their uses
07/01/2014US8765767 Positive allosteric modulators of mGluR2
07/01/2014US8765766 Pyrimidine derivatives which are antagonists of the vitronectin receptor
07/01/2014US8765765 Metabolites of (thio) carbamoyl-cyclohexane derivatives
07/01/2014US8765764 2-acylaminothiazole derivative or salt thereof
07/01/2014US8765763 Substituted piperazines as CGRP antagonists
07/01/2014US8765762 Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome
07/01/2014US8765761 6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor
07/01/2014US8765760 [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases
07/01/2014US8765759 Monocyclic CGRP receptor antagonists
07/01/2014US8765758 Compositions and methods for eye whitening
07/01/2014US8765754 Pyrrolotriazine compounds
07/01/2014US8765752 3-hydroxyisothiazole 1-oxide derivatives
07/01/2014US8765751 Compounds useful as inhibitors of ATR kinase
07/01/2014US8765750 Piperazine compound having a PGDS inhibitory effect
07/01/2014US8765749 1,6-disubstituted indole compounds as protein kinase inhibitors
07/01/2014US8765748 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/01/2014US8765747 Fused 2-aminothiazole compounds
07/01/2014US8765746 Heteroaryls and uses thereof
07/01/2014US8765745 Compounds for enzyme inhibition
07/01/2014US8765744 Azaspirohexanones
07/01/2014US8765743 Compounds
07/01/2014US8765742 Crystalline methylthioninium chloride hydrates
07/01/2014US8765741 5,6-dihydro-1H-pyridin-2-one compounds
07/01/2014US8765740 Cytotoxic benzodiazepine derivatives
07/01/2014US8765739 Azetidine compound and pharmaceutical use thereof
07/01/2014US8765738 Carbazole compounds and therapeutic uses of the compounds
07/01/2014US8765737 Methods and compositions for preparing and purifying noribogaine
07/01/2014US8765736 Benzenesulfonamide compounds and the use thereof
07/01/2014US8765735 Isoxazolines as inhibitors of fatty acid amide hydrolase
07/01/2014US8765734 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
07/01/2014US8765733 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands
07/01/2014US8765732 Aryl- or heteroaryl-substituted benzene compounds
07/01/2014US8765731 Benzimidazole analogues for the treatment or prevention of flavivirus infections
07/01/2014US8765730 1-hydroxyimino-3-phenyl-propanes
07/01/2014US8765729 Cancer therapy
07/01/2014US8765728 [1,5]-diazocin derivatives
07/01/2014US8765727 Macrocyclic compounds and their use as kinase inhibitors
07/01/2014US8765726 Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiation
07/01/2014US8765724 Methods of using ophthalmic compositions comprising povidone-iodine
07/01/2014US8765723 Analogues of cilostazol
07/01/2014US8765722 Inhibitors of flaviviridae viruses
07/01/2014US8765721 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof
07/01/2014US8765720 Combination therapy for the treatment of multiple myeloma
07/01/2014US8765719 Therapeutic drug for adult T-cell leukemia
07/01/2014US8765717 Meloxicam and glucosamine formulation and uses thereof
07/01/2014US8765716 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
07/01/2014US8765714 Sulphated hyaluronic acid for treating degenerative osteoarthritis
07/01/2014US8765713 Method for determination of sensitivity to anti-cancer agent
07/01/2014US8765712 Agent for preventing and treating pityriasis versicolor
07/01/2014US8765711 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage
07/01/2014US8765710 2′,4′-substituted nucleosides as antiviral agents
07/01/2014US8765698 Methods and products for reawakening retrocyclins
07/01/2014US8765697 Pesticide compositions exhibiting enhanced activity
07/01/2014US8765696 Steroid compound
07/01/2014US8765694 Method for treating obesity
07/01/2014US8765693 Method of inhibiting premature aging of human skin caused by exposure to infrared radiation
07/01/2014US8765692 Modified-galactosyl ceramides for staining and stimulating natural killer T cells
07/01/2014US8765691 Osmolytes for the treatment of allergic or viral respiratory diseases
07/01/2014US8765690 Treatment of cancer with glufosfamide in patients not receiving insulin therapy
07/01/2014US8765685 Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)
07/01/2014US8765681 IAP BIR domain binding compounds
07/01/2014US8765680 Method for administering omega-conopeptide
07/01/2014US8765676 Calcium sensing receptor modulating compounds and pharmaceutical use thereof
07/01/2014US8765674 Methods useful in the treatment of bone resorption diseases
07/01/2014US8765668 Methods of synthesis of β-aminobutyryl substituted compounds
07/01/2014US8765665 Albumin-free factor VIII formulations
07/01/2014US8765657 Antimicrobially effective use solutions comprising combinations of isothiazolones and amines
07/01/2014US8765432 Targeted drug phosphorylcholine polymer conjugates
07/01/2014US8765376 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator
07/01/2014US8765198 Anti-stretch mark active agent, and compositions containing same
07/01/2014US8765194 Natural—topical analgesic and anti-inflammatory composition
07/01/2014US8765185 Granules for pharmaceutical preparations, methods and apparatus for their production
07/01/2014US8765178 Controlled release formulations and associated methods
07/01/2014US8765177 Bioadhesive progressive hydration tablets
07/01/2014US8765175 Sustained release formulation of nalbuphine
07/01/2014US8765164 Poly(ester urea) polymers and methods of use
07/01/2014US8765157 Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, glycerin, and zinc oxide
07/01/2014US8765156 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound